Hi there

If you’re on this site, you’re probably trying to learn a bit more about me. I’m currently the head of AI at a stealth biotechnology startup (pi.bio) focused on targeting protein-protein interactions therapeutically. I previously worked as a scientific advisor at Eli Lilly, and prior to that I have held various academic research positions.

My work focuses on using computational and synthetic biology to accelerate the development of next-generation medicines. I have had a long interest in developing parallelized methods for screening biotherapeutics, and have been lucky enough to work across many interesting modalities (ex. small molecules, recombinant proteins/peptides, gene therapies, etc.). We can move a lot faster if we test things in parallel, and drug development definitely needs speeding up.

Brief bio

I received a BS in chemical engineering in 2016 from the University of Texas at Austin, and a PhD in bioengineering in 2022 from the University of California, San Diego; My PhD advisor was Prashant Mali. I grew up in central Texas, and currently live in New York City with my wife Mia.

Research interests

I am broadly curious, and am not particularly focused on any one disease. At work, I largely focus on questions like:

• How do we design better protein therapeutics for hard to drug targets? How can we test them with greater throughput (ideally in a pooled format)?
• How do we analyze and model large scale screening datasets, which often have millions of observations from each animal/condition?
• What targets/diseases are the most in need of innovative new medicines?
• How can we accelerate the commercialization of a novel medicine?

Outside of my day job:

• I’m deeply interested in art, economics, and human behavior (sometimes the intersection of these).
• I am most likely reading, riding my bike, or playing tennis/basketball.